Est. 2026 · United Kingdom
A professional society
for evidence-informed
longevity medicine.
UKSML is a clinician-led society advancing safe, evidence-informed longevity medicine in the UK through education, collaborative research, and policy engagement.
For practising clinicians · researchers · policy leaders
15+
Average years UK adults spend in poor health at end of life
63
Average UK healthspan — the years we aim to extend
33%
Of chronic disease burden estimated to be preventable
#1
The first dedicated professional society for longevity medicine in the UK
Who We Are
The UK's first clinician-led society for longevity medicine.
2026
UKSML is a clinician-led society advancing safe, evidence-informed longevity medicine in the UK through education, collaborative research, and policy engagement.
"We critically evaluate emerging diagnostics and therapies and only recommend interventions when benefit, risk, and cost are supported by robust evidence."
Clinical Excellence
Implementation of geroscience and metabolic science in day-to-day practice, with clear guardrails against hype and non-evidence-informed interventions. We define longevity medicine in conservative, geroscience-aligned terms: optimising healthspan and delaying age-related functional decline.
Research & Innovation
A conduit between clinics, academic groups, and industry to standardise protocols, biomarkers, and outcomes for healthy longevity clinics. We support translation pathways that connect bench science to patient-facing implementation.
Policy & Systems Change
A recognised voice informing the NHS, royal colleges, and government on the safe, equitable integration of longevity and healthy ageing into mainstream care — supporting models that translate into public systems, not just private clinics.
Dr Mayoni Gooneratne
MBBS, BSc, MRCS, AFMCP
Dr Gooneratne is a former NHS colorectal and pelvic floor surgeon who now specialises in functional and longevity medicine with a particular focus on metabolic women's health and menopause. She is the founder and lead practitioner at Human Health + SkinFIT at The Clinic by Dr Mayoni, integrating hormonal and gut-focused functional medicine with regenerative aesthetic treatments to optimise healthspan for women in midlife and beyond.
Drawing on her surgical research background — including a fellowship with Professor Norman Williams — and Institute for Functional Medicine training (AFMCP), she has designed evidence-informed programmes such as THRIVE and the BODYFIT Metabolic Reset, targeting metabolic dysfunction, hormone balance, and long-term disease prevention. She is an active educator and speaker, delivering clinician training and contributing to medical and consumer media on longevity and metabolic health.
What We Do
Four flagship programmes
Concrete, named deliverables — not vague community promises. Each programme has defined outputs, clear governance, and a specific call to action.
UKSML Clinical Forum
Monthly grand rounds & case conferences
A regular virtual forum for specialist clinicians to present and discuss multimodal longevity and metabolic cases — including where interventions didn't work. Grounded in honest, evidence-critical practice.
→Monthly virtual grand rounds and case conferences
→Focus on multimodal longevity and metabolic cases
→De-identified case library and pragmatic practice notes
→Peer review of clinical protocols and emerging evidence
UK Longevity Clinic Network
A standards-based clinic directory
A network of clinics and services committed to defined standards of evidence, ethics, and patient safety. Aligned with emerging best-practice frameworks for healthy longevity clinics in public and private settings.
→Clinics committed to evidence, ethics, and safety standards
→Alignment with international healthy longevity clinic frameworks
→Referral directory for patients and clinicians
→Shared outcome measures and anonymised data contribution
Geroscience Education Pathway
Structured learning — Foundation to Advanced
A structured educational pathway — not just webinars. Foundation modules cover geroscience, metabolic health, and ethical boundaries of emerging therapies. Advanced modules address biomarker selection, risk stratification, and case-based protocols.
→Foundation: geroscience, metabolic health, ethical prescribing
→Advanced: biomarker selection, risk stratification, protocols
→Prioritises lifestyle, cardiometabolic, and early detection first
→Experimental modalities addressed with evidence-grade framing
Policy & Standards Taskforce
Clinical governance for longevity medicine
A named working group producing policy briefs for commissioners and NHS leaders, and model clinical governance frameworks for longevity clinics — covering indications, consent, outcome tracking, and safety monitoring.
→Policy briefs for NHS commissioners and royal colleges
→Model governance frameworks for longevity clinics
→Informed consent and safety monitoring standards
→Advisory panels for ICS leads and public health partners
Our Scientific Position
Evidence-informed. Not hype-driven.
We define longevity medicine in conservative, geroscience-aligned terms: optimising healthspan and delaying age-related functional decline. We critically evaluate emerging diagnostics and therapies and only recommend interventions when benefit, risk, and cost are supported by robust evidence.
✓
✕
⛉
"We are complementary to, not competitive with, existing societies such as BSLM, BOMSS, BGS, and BCFM. We occupy a distinct geroscience-focused domain and work alongside all relevant professional bodies."
Roadmap
2026 — 2027 milestones
Q2 2026
Q3 2026
Q4 2026
Q1–Q2 2027
Research
From the lab to the clinic.
UKSML operates at the intersection of clinical practice and research. We create structured pathways for translating cutting-edge longevity science into evidence-informed clinical practice — closing the gap between what we know and what we do.
"The development of this field must rest on the same scientific foundation as all other medicine."
UKSML Founding Principle
Education
Evidence-based education for practising clinicians.
UKSML members access a growing library of clinical overviews, expert-led masterclasses, and evidence reviews — all grounded in peer-reviewed science and designed for specialist clinicians who want to integrate longevity medicine into their practice.
Biological Age & Healthspan
Cardiovascular Risk in Longevity Medicine
Senolytic Therapies: Current Evidence
Cardiometabolic Health & Longevity
Full access available to UKSML members.
Membership
Join the founding cohort shaping the future of longevity medicine.
We are recruiting our first 100 founding members — clinicians and researchers who will help shape the society's direction, contribute to its governance, and be listed as founding members on the UKSML website. Healthy longevity services are already emerging across London and the UK; this is where you come to do it responsibly.
Practising clinicians
Clinical guidelines, case conferences, clinical pathways, and peer network
Academic clinicians
Access to clinics, data standards, pilot networks, and research collaboration
Policy makers
Briefings, advisory panels, governance frameworks, and clinical partners
Allied professionals
Training aligned with medical governance and a clearly defined professional scope
Core Clinical Member
GPs, physicians, endocrinologists, geriatricians, lifestyle/functional clinicians, sports and metabolic physicians seeking to integrate longevity into practice.
Access to the UKSML Clinical Forum and case library
Geroscience Education Pathway (Foundation + Advanced)
Clinical guidelines, protocols, and position papers
Invitations to UKSML summits and masterclasses
Peer network of UK specialist longevity clinicians
Academic & Research Member
Clinicians and researchers in ageing, metabolomics, biomarkers, and clinical trials seeking translation pathways and patient-facing implementation routes.
Access to clinic data standards and pilot networks
Collaboration on shared outcome measures and registries
Connection to the UK Longevity Clinic Network
Input into UKSML research agenda and publications
Pathways to joint clinical-academic initiatives
Policy & Affiliate Member
ICS leads, commissioners, public health professionals, royal college representatives, think-tank fellows, and allied health professionals with a clearly defined clinical scope.
Access to UKSML policy briefs and governance frameworks
Participation in the Policy & Standards Taskforce
Advisory panel membership and commissioner briefings
Engagement with NHS integration workstreams
Structured scope — not a generic wellness group
Frequently Asked Questions
Longevity medicine focuses on optimising healthspan and delaying age-related functional decline — not promising life extension per se. It draws on geroscience, preventive medicine, metabolic health, and multiple clinical specialties. Our primary tools are lifestyle interventions, cardiometabolic risk factor optimisation, and early detection of age-related conditions.
Longevity clinics are proliferating across the UK without consistent governance, evidence standards, or clinical frameworks. UKSML fills that gap — providing shared standards, education, and a bridge between clinics, academia, and policy. We complement existing societies (BSLM, BOMSS, BGS, BCFM) rather than competing with them.
Membership is open to qualified doctors, specialist clinicians, and medical researchers with a genuine professional interest in longevity medicine and healthy ageing. We welcome clinicians from NHS, academic, and private practice — and explicitly support models that can translate into public systems.
We are committed to evidence-informed medicine. We critically evaluate emerging diagnostics and therapies and only recommend interventions when benefit, risk, and cost are supported by robust evidence. We explicitly avoid endorsing unproven or exploitative practices, including anti-ageing claims, unnecessary extreme testing panels, and unregulated therapies
Events
Where the field comes together.
Summits, masterminds, and masterclasses — designed for specialist clinicians who want to stay at the frontier of longevity medicine.
Events will go here
UKSML Founding Summit 2026
The inaugural gathering of the UK Society of Medical Longevity — bringing together founding members, keynote speakers, and leading voices in longevity medicine for a landmark day of science, collaboration, and vision.
News & Insights
From the frontier of longevity science.
UKSML Launches as the UK's First Dedicated Longevity Medicine Society
The UK Society of Medical Longevity announces its founding, bringing together specialist doctors and researchers to advance evidence-informed longevity medicine and define clinical standards for the field in the UK.
The Hallmarks of Ageing: A Clinical Primer for Practising Physicians
A structured overview of the twelve hallmarks of biological ageing — from genomic instability and telomere attrition to altered intercellular communication — and their relevance to clinical longevity medicine.
Measuring Biological Age: Which Tools Are Ready for Clinical Use?
An evidence-informed review of biological age assessment tools — epigenetic clocks, proteomics-based measures, and composite biomarker panels — and their current clinical utility.
Stay at the frontier of longevity medicine.
Receive the latest evidence reviews, clinical insights, society news, and event invitations direct to your inbox.
Contact
Get in touch.
Whether you are a specialist doctor interested in membership, a researcher seeking collaboration, a media enquiry, or an organisation wishing to partner with UKSML — we would love to hear from you.
Ready to join the society?
Founding member applications are now open for specialist doctors and researchers committed to advancing longevity medicine in the UK.